83 related articles for article (PubMed ID: 29792006)
1. Antisense molecular biology.
Datar RH; Ishwad CS; Datar BR; Bishey AN
Natl Med J India; 1991; 4(6):275-281. PubMed ID: 29792006
[No Abstract] [Full Text] [Related]
2. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
3. Antisense strategies for the control of aberrant gene expression.
Sczakiel G
J Hematother; 1994; 3(4):305-13. PubMed ID: 7735826
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides.
Mandiyan S; Schumacher C; Cioffi C; Sharif H; Yuryev A; Lappe R; Monia B; Hanson S; Goff S; Wennogle L
Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):539-48. PubMed ID: 9450911
[TBL] [Abstract][Full Text] [Related]
7. Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.
Engelhard HH
Cancer Control; 1998 Mar; 5(2):163-170. PubMed ID: 10761027
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
Mirabelli CK; Bennett CF; Anderson K; Crooke ST
Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotide inhibition as a potent strategy in plant biology: identification of SUSIBA2 as a transcriptional activator in plant sugar signalling.
Sun C; Höglund AS; Olsson H; Mangelsen E; Jansson C
Plant J; 2005 Oct; 44(1):128-38. PubMed ID: 16167901
[TBL] [Abstract][Full Text] [Related]
10. The landscape of antisense gene expression in human cancers.
Balbin OA; Malik R; Dhanasekaran SM; Prensner JR; Cao X; Wu YM; Robinson D; Wang R; Chen G; Beer DG; Nesvizhskii AI; Chinnaiyan AM
Genome Res; 2015 Jul; 25(7):1068-79. PubMed ID: 26063736
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides in the study of central mechanisms of the cardiovascular regulation.
Culman J
Exp Physiol; 2000 Nov; 85(6):757-67. PubMed ID: 11187969
[TBL] [Abstract][Full Text] [Related]
12. Human-specific antisense transcripts induced by the insertion of transposable element.
Kim DS; Hahn Y
Int J Mol Med; 2010 Jul; 26(1):151-7. PubMed ID: 20514435
[TBL] [Abstract][Full Text] [Related]
13. Application of a dicistronic mRNA expression vector to antisense RNA expression in mammalian cells.
Yamauchi Y; Kobayashi M; Tanaka A
Antisense Nucleic Acid Drug Dev; 1996; 6(4):305-9. PubMed ID: 9012867
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional transcription is an inherent feature of Giardia lamblia promoters and contributes to an abundance of sterile antisense transcripts throughout the genome.
Teodorovic S; Walls CD; Elmendorf HG
Nucleic Acids Res; 2007; 35(8):2544-53. PubMed ID: 17403692
[TBL] [Abstract][Full Text] [Related]
15. [Uptake kinetics of hTERT antisense molecular probe by cells and its biological properities].
Wang RF; Liu M; Zhang CL; Yan P; Yu MM
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):437-41. PubMed ID: 19727234
[TBL] [Abstract][Full Text] [Related]
16. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Interference in Convergent Promoters as a Means for Tunable Gene Expression.
Bordoy AE; Varanasi US; Courtney CM; Chatterjee A
ACS Synth Biol; 2016 Dec; 5(12):1331-1341. PubMed ID: 27346626
[TBL] [Abstract][Full Text] [Related]
18. Multiple-gene silencing using antisense RNAs in Escherichia coli.
Nakashima N; Goh S; Good L; Tamura T
Methods Mol Biol; 2012; 815():307-19. PubMed ID: 22131001
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring antisense RNA: function and mechanisms of action.
Werner A; Sayer JA
Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):343-9. PubMed ID: 19491676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
